U.S. officials have confirmed 1,267 measles cases across 27 outbreaks as of July 1 — a sharp increase from the 285 confirmed cases in 2024, according to CDC data.  Baltimore-based Johns Hopkins ...

After President Donald Trump signed the One Big Beautiful Bill Act July 4 health systems are calculating the potential effects of the new law and preparing new strategies accordingly. The legislation ...

U.S. medical supply manufacturers are voicing support for the newly passed One Big Beautiful Bill Act, which includes a series of tax and trade measures aimed at boosting domestic production of ...

Weeks after HHS Secretary Robert F. Kennedy Jr. announced the CDC would stop recommending healthy children and pregnant women receive routine COVID-19 vaccinations, national healthcare groups filed a ...

Brian Roland was appointed CEO of Elkview General Hospital in Hobart, Okla., according to a July 7 news release shared with Becker’s. Mr. Roland brings three decades of healthcare experience to the ...

West Reading, Pa.-based Tower Health has shared plans to lay off less than 0.5% of total employee headcount, including management-level roles, across the system, according to a July 7 statement shared ...

Cuts at the FDA are slowing inspections of overseas drug manufacturers, prompting concerns from former and current employees that medication safety could be at risk, ProPublica reported July 7. Dozens ...

Wyatt Chocklett was appointed CEO of Dickson, Tenn.-based TriStar Horizon Medical Center, part of Nashville, Tenn.-based HCA Healthcare, according to a July 7 news release shared with Becker’s. Most ...

Between July 7, 2023, and June 30, 2024, Houston-based University of Texas MD Anderson had the lowest rate of Clostridioides difficile infections among cancer hospitals exempt from reporting to ...

Christopher Clark has been named assistant CFO of Richmond, Va.-based Henrico, Parham and Retreat Doctors’ Hospital, according to a July 2 LinkedIn post. The hospital is part of Nashville, Tenn.-based ...

A late-stage trial testing Novartis’ Cosentyx in individuals with giant cell arteritis failed to meet its primary endpoint. The phase 3 study tested Cosentyx alongside a 26-week steroid taper and ...

A new study suggests that the introduction of a real-time prescription benefit tool did not lead to meaningful changes in prescription spending or medication use among Medicare Advantage beneficiaries ...